 |
 |
 |
 |
 |
 |
||||
 |
 |
 |
 |
 |
 |
 |
||||||||
|
||||||||||||||
|
|
Protexia™ Abstracts The following abstracts were presented at the Bioscience 2004 Medical Defense Review held in Maryland on May 16-21, 2004. In Vitro and In Vivo Characterization of Recombinant Human Butyrylcholinesterase (Protexia ) as a Potential Nerve Agent Bioscavenger Cerasoli et al. Transgenically Produced Human Butyrylcholinesterase (Protexiatm): Initial Pharmacokinetic Characterization of a Pegylated Form Wilgus et al. Characterization of Recombinant Human Butyrylcholinesterase (Protexia™) Produced in the Milk of Transgenic Goats Karatzas et al. |
